BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Divis Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
ISIN Demat
INE361B01024
Book Value (Rs)
578.2640535
NSE Symbol
DIVISLAB
Divident Yield %
0.46
Market Cap
(Rs In Cr.)
172,442
P/E (TTM)
68.59
EPS (TTM)
94.7
Face Value
(Rs)
2
Back
Divi's Laboratories consolidated net profit rises 35.10% in the September 2025 quarter
07-Nov-25   Hrs IST

Net profit of Divi's Laboratories rose 35.10% to Rs 689.00 crore in the quarter ended September 2025 as against Rs 510.00 crore during the previous quarter ended September 2024. Sales rose 16.12% to Rs 2715.00 crore in the quarter ended September 2025 as against Rs 2338.00 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales2715.002338.00 16
OPM %32.7130.62 -
PBDT1025.00821.00 25
PBT912.00722.00 26
NP689.00510.00 35

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)